Alzheimer's Treatment Centers Of America
Medical Practice, 3343 Peachtree Rd Ne, Dunwoody, Georgia, 30326, United States, 11-50 Employees
Phone Number: +14*********
Who is ALZHEIMER'S TREATMENT CENTERS OF AMERICA
Alzheimer's Treatment Centers of America (ATCA ) Only Treats Alzheimers, Dementia, Cognitive Impairment and Memory Loss. ---- INVESTMENT OPPORTUNITY FOR ACCREDITED INVESTORS NOW AVAILABLE...
Read More
- Headquarters: 3343 Peachtree Rd Ne, Dunwoody, Georgia, 30326, United States
- Date Founded: 2019
- Employees: 11-50
- Revenue: $50 Million to $100 Million
- Active Tech Stack: See technologies
Industry: Medical Practice
SIC Code: 8011 | NAICS Code: 621111 | Show More
Does something look wrong? Fix it. | View contact records from ALZHEIMER'S TREATMENT CENTERS OF AMERICA
Alzheimer's Treatment Centers of America Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Alzheimer's Treatment Centers of America
Answer: Alzheimer's Treatment Centers of America's headquarters are located at 3343 Peachtree Rd Ne, Dunwoody, Georgia, 30326, United States
Answer: Alzheimer's Treatment Centers of America's phone number is +14*********
Answer: Alzheimer's Treatment Centers of America's official website is https://alzheimerstreatmentcentersofamerica.com
Answer: Alzheimer's Treatment Centers of America's revenue is $50 Million to $100 Million
Answer: Alzheimer's Treatment Centers of America's SIC: 8011
Answer: Alzheimer's Treatment Centers of America's NAICS: 621111
Answer: Alzheimer's Treatment Centers of America has 11-50 employees
Answer: Alzheimer's Treatment Centers of America is in Medical Practice
Answer: Alzheimer's Treatment Centers of America contact info: Phone number: +14********* Website: https://alzheimerstreatmentcentersofamerica.com
Answer: Alzheimer's Treatment Centers of America (ATCA ) Only Treats Alzheimers, Dementia, Cognitive Impairment and Memory Loss. ---- INVESTMENT OPPORTUNITY FOR ACCREDITED INVESTORS NOW AVAILABLE WITH SERIES A ROUND OF FINANCING. ---- ATCA is at the convergence of medicine and technology, harnessing the power of patented Artificial Intelligence (AI) protocol to help patients fight back against Alzheimers disease and memory loss. It utilizes the immense analytical power of supercomputers to identify patterns, gives automated insights to physicians to improve decision making, streamlines diagnoses, and improves clinical outcomes. Each patient is unique. Consequently, ATCA has a data-intensive patient intake process. The amount of data that we gather on each patient is massive: - Labs - Cognitive assessment - DNA testing - Genetic food typing - Personal medical history - Family medical history - Social history - Exercise history - Prescriptions - Supplements - Treatments - Sleep issues -- literally thousands of data points. POSITIVE OBSERVATIONAL STUDY RESULTS In the observational study of the AI protocol, 75% of the patients had no further decline in their mild cognitive impairment * TheStudy is peer reviewed and published in a scientific journal. (Study is available on website under Patient Resources) *Each patient is unique. No representation is being made that new patients would have similar results. Each patient responds to the protocol based on their current condition. SPEED OF ANALYSIS & HUMAN/AI INTERFACE The AI creates a comprehensive 30-page report for practitioner in one day that could have taken the practitioner a year or more to prepare Our ATCA Practitioner is the Human/AI Interface and makes the final decisions for treatments. ESG OPPORTUNITY TO BENEFIT OTHERS Alzheimer's disease represents a huge unmet medical need for diagnosis and treatment.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Sign in to CIENCE GO Data to uncover contact details
Free credits every month